Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Tolerability, Safety, And Efficacy, of DMT310 In Patients With Acne Vulgaris

NCT03536637 is registered in ClinicalTrials.gov with Dermata Therapeutics as lead sponsor.

NCT NCT03536637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03536637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Tolerability, Safety, And Efficacy, of DMT310 In Patients With Acne Vulgaris
Lead sponsor
Dermata Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
May 22, 2018
Completion date
January 28, 2019
Enrollment
121 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris